Diagnos Inc.
ADK.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -35.90% | -42.66% | -57.62% | -65.85% | -66.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -35.90% | -42.66% | -57.62% | -65.85% | -66.87% |
| Cost of Revenue | 4.24% | 10.60% | 18.81% | 24.27% | 14.91% |
| Gross Profit | -14.80% | -34.74% | -94.93% | -167.70% | -227.13% |
| SG&A Expenses | 24.96% | 13.35% | -2.56% | -10.35% | -16.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.91% | 12.45% | 3.77% | -0.26% | -7.72% |
| Operating Income | -22.02% | -18.71% | -14.44% | -14.03% | -6.81% |
| Income Before Tax | -21.50% | -21.11% | -21.38% | -23.18% | -17.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.50% | -21.11% | -21.38% | -23.18% | -17.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.50% | -21.11% | -21.38% | -23.18% | -17.82% |
| EBIT | -22.02% | -18.71% | -14.44% | -14.03% | -6.81% |
| EBITDA | -22.91% | -18.84% | -14.47% | -14.23% | -6.66% |
| EPS Basic | -4.76% | -11.11% | -14.18% | -17.78% | -14.13% |
| Normalized Basic EPS | -5.61% | -11.73% | -14.37% | -17.16% | -13.29% |
| EPS Diluted | -4.76% | -11.11% | -14.18% | -17.78% | -14.13% |
| Normalized Diluted EPS | -5.61% | -11.73% | -14.37% | -17.16% | -13.29% |
| Average Basic Shares Outstanding | 14.85% | 8.94% | 6.42% | 4.63% | 3.13% |
| Average Diluted Shares Outstanding | 14.85% | 8.94% | 6.42% | 4.63% | 3.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
